Xcout Intel
Motif Neurotech, Inc.
Motif Neurotech is a medical equipment and therapeutic brain-computer interface company headquartered in Houston, Texas. The company develops minimally invasive bioelectronic devices designed to provide therapeutic relief for mental health disorders.
Subscribe to see Motif Neurotech, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Motif Neurotech, Inc. at a glance
Motif Neurotech, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $15.3M in January 2024. Xcout recorded 5 job postings from Motif Neurotech, Inc. in the last 90 days.
Motif Neurotech, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Motif Neurotech, Inc.
Xcout recorded 5 job postings from Motif Neurotech, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Motif Neurotech, Inc.'s hiring signals →
Tech stack
Motif Neurotech, Inc. competitors
A few of Motif Neurotech, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
NeuroStar provides advanced, non-invasive transcranial magnetic stimulation (TMS) treatments designed for patients suffering from depression. The company is headquartered in Malvern, Pennsylvania, and offers physician-recommended in-office therapy.
Blackrock Neurotech develops innovative brain-computer interface technologies designed to restore function, communication, and movement for individuals with paralysis and neurological disorders.
NeuroThera develops a clinical-grade transcranial photobiomodulation platform that delivers near-infrared laser light to targeted brain regions. The company's non-invasive technology aims to treat major neurological and psychiatric conditions, including major depressive disorder, Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke recovery.
Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.
Get Motif Neurotech, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Motif Neurotech, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Motif Neurotech, Inc. in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access